Are you over 21 years old?
This website requires you to be 21 years or older to enter our website and see the content.
Your access is restricted because of your age.
Research Purposes Only. NOT FOR HUMAN CONSUMPTION
$150.00
Mazdutide (also known as IBI362 or LY3305677) is an investigational synthetic peptide and dual agonist of glucagon-like peptide-1 (GLP-1) and glucagon receptors, mimicking oxyntomodulin. Administered weekly via subcutaneous injection, it promotes weight loss by suppressing appetite, enhancing insulin secretion, and increasing energy expenditure, while improving glucose control. It’s under phase 3 trials for obesity and type 2 diabetes, showing up to 15.4% weight loss over 24 weeks at 9 mg doses and HbA1c reductions of 1.41–1.67% at 3–6 mg doses in phase 2 studies.
THIS IS NOT FOR HUMAN CONSUMPTION. SOLD FOR RESEARCH ONLY!
By pressing the button “Subscribe”, you confirm that you have read
and are agreeing to our Terms of Service regarding the storage of the
data submitted through this form.
Please note that all products featured on this website are intended exclusively for research and development purposes. They are not designed for any form of human consumption. The claims made on this website have not undergone evaluation by the U.S. Food and Drug Administration.
Neither the statements nor the products of this company aim to diagnose, treat, cure, or ward off any disease.
Penguin Peptides is a chemical supplier. Penguin Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Penguin Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.